Recent studies also suggest that morin may increase anticancer activity of some conventional anticancer agents, e.g., fludarabine, inhibiting low molecular weight protein tyrosine phosphatase (LMW-PTP) [32], and may inhibit proliferation, migration, and invasion of EJ cells of bladder cancer via many different intracellular mechanisms [33]. This evidence concerns the gene ACP1 and urinary bladder cancer.